Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1393 to 1442 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1393\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
membrane-associated nucleic acid binding protein. [source:refseq;acc:nm\_018835]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.47\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.875\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02148\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1394\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polypyrimidine tract-binding protein 1 (ptb) (heterogeneous nuclear ribonucleoprotein i) (hnrnp i) (57 kda rna-binding protein pptb-1). [source:swissprot;acc:p26599]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1395\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
growth-arrest-specific protein 7 (gas-7). [source:swissprot;acc:o60861]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
213.876\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1396\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eyes absent homolog 1. [source:swissprot;acc:q99502]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.463\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.872\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02147\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1397\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s8. [source:swissprot;acc:p09058]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.049\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02145\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1398\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eyes absent homolog 4. [source:swissprot;acc:o95677]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.449\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.864\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02144\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1399\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eyes absent homolog 2. [source:swissprot;acc:o00167]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.417\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.848\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02137\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1400\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-7 (activating transcription factor 7) (transcription factor atf-a). [source:swissprot;acc:p17544]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.667\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.118\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02125\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1401\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-2 (activating transcription factor 2) (camp response element binding protein cre- bp1) (hb16). [source:swissprot;acc:p15336]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.657\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02124\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1402\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
colorectal mutant cancer protein (mcc protein). [source:swissprot;acc:p23508]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.682\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.329\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0212\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1403\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
enoyl-coa hydratase, mitochondrial precursor (ec 4.2.1.17) (short chain enoyl-coa hydratase) (sceh) (enoyl-coa hydratase 1). [source:swissprot;acc:p30084]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
184.656\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
180.823\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1404\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3b subunit 4 (spliceosome associated protein 49) (sap 49) (sf3b50) (pre-mrna splicing factor sf3b 49 kda subunit). [source:swissprot;acc:q15427]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
232.752\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02104\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1405\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 8 (eif3 p110) (eif3c). [source:swissprot;acc:q99613]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
245.532\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.483\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.021\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1406\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor nr6a1 (germ cell nuclear factor) (gcnf) (retinoid receptor-related testis specific receptor) (rtr). [source:swissprot;acc:q15406]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.833\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.456\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1407\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd repeat and fyve domain containing 1 isoform 1; phosphoinositide-binding protein sr1; wd40 and fyve domain containing 1. [source:refseq;acc:nm\_020830]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.104\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.424\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02096\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1408\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stromal interaction molecule 1 precursor. [source:swissprot;acc:q13586]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
206.102\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
210.42\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02095\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1409\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trap/mediator complex component trap25. [source:refseq;acc:nm\_080651]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1410\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd repeat- and fyve domain-containing protein 2; wd40 and fyve domain containing 2. [source:refseq;acc:nm\_052950]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.417\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1411\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 4 (ec 2.7.1.-) (p21-activated kinase 4) (pak-4). [source:swissprot;acc:o96013]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
206.102\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
210.42\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1412\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyposis locus protein 1 (tb2 protein). [source:swissprot;acc:q00765]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1413\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coa dehydrogenase, medium-chain specific, mitochondrial precursor (ec 1.3.99.3) (mcad). [source:swissprot;acc:p11310]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1414\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyposis locus protein 1-like 1; likely ortholog of mouse polyposis locus protein 1-like 1. [source:refseq;acc:nm\_138393]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1415\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stromal interaction molecule 2 precursor. [source:swissprot;acc:q9p246]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1416\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 7 (ec 2.7.1.-) (p21-activated kinase 7) (pak-7) (pak-5). [source:swissprot;acc:q9p286]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1417\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase a5. [source:refseq;acc:nm\_080385]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
203.979\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
208.229\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02084\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1418\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase b precursor (ec 3.4.17.2) (pancreas-specific protein) (pasp). [source:swissprot;acc:p15086]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1419\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neutral and basic amino acid transport protein rbat (b(0,+)-type amino acid transport protein) (nbat) (d2h). [source:swissprot;acc:q07837]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1420\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aminoacylase-1 (ec 3.5.1.14) (n-acyl-l-amino-acid amidohydrolase) (acy-1). [source:swissprot;acc:q03154]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1421\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acid ceramidase precursor (ec 3.5.1.23) (acylsphingosine deacylase) (n-acylsphingosine amidohydrolase) (ac) (putative 32 kda heart protein) (php32). [source:swissprot;acc:q13510]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.076\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.391\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1422\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase a1 precursor (ec 3.4.17.1). [source:swissprot;acc:p15085]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
203.979\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.229\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1423\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine-rich protein 1 (cysteine-rich intestinal protein) (crip) (cysteine-rich heart protein) (hcrhp). [source:swissprot;acc:p50238]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.152\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.659\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02074\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1424\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sodium/potassium-transporting atpase alpha-1 chain precursor (ec 3.6.3.9) (sodium pump 1) (na+/k+ atpase 1). [source:swissprot;acc:p05023]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
214.717\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.157\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02068\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1425\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cathepsin l2 precursor (ec 3.4.22.43) (cathepsin v) (cathepsin u). [source:swissprot;acc:o60911]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1426\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cathepsin l precursor (ec 3.4.22.15) (major excreted protein) (mep). [source:swissprot;acc:p07711]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1427\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sodium/potassium-transporting atpase alpha-3 chain (ec 3.6.3.9) (sodium pump 3) (na+/k+ atpase 3) (alpha(iii)). [source:swissprot;acc:p13637]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1428\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sodium/potassium-transporting atpase alpha-2 chain precursor (ec 3.6.3.9) (sodium pump 2) (na+/k+ atpase 2). [source:swissprot;acc:p50993]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1429\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd repeat domain 26. [source:refseq;acc:nm\_025160]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.351\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02057\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1430\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial precursor (ec 3.6.1.23) (dutpase) (dutp pyrophosphatase). [source:swissprot;acc:p33316]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.114\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
190.925\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02037\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1431\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uv excision repair protein rad23 homolog a (hhr23a). [source:swissprot;acc:p54725]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
220.987\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
225.468\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02028\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1432\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 4 (26s proteasome regulatory subunit s5a) (rpn10) (multiubiquitin chain binding protein) (antisecretory factor-1) (af) (asf). [source:swissprot;acc:p55036]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1433\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate 5-phosphatase ocrl-1 (ec 3.1.3.36) (lowe's oculocerebrorenal syndrome protein). [source:swissprot;acc:q01968]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1434\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uv excision repair protein rad23 homolog b (hhr23b) (xp-c repair complementing complex 58 kda protein) (p58). [source:swissprot;acc:p54727]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1435\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vi. [source:swissprot;acc:q9um54]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1436\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to ecotropic viral integration site 5; neuroblastoma stage 4s gene. [source:refseq;acc:nm\_145245]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.829\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.493\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02022\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1437\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ecotropic viral integration site 5; neuroblastoma stage 4s gene. [source:refseq;acc:nm\_005665]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1438\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
geranylgeranyl transferase type i beta subunit (ec 2.5.1.-) (type i protein geranyl-geranyltransferase beta subunit) (ggtase-i-beta). [source:swissprot;acc:p53609]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
225.039\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
229.573\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02015\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1439\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid desaturase 3; linoleoyl-coa desaturase (delta-6-desaturase)-like 3; delta-6 fatty acid desaturase. [source:refseq;acc:nm\_021727]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1440\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 4 (smad 4) (mothers against dpp homolog 4) (deletion target in pancreatic carcinoma 4) (hsmad4). [source:swissprot;acc:q13485]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1441\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid desaturase 2; linoleoyl-coa desaturase (delta-6-desaturase)-like 2; delta-6 fatty acid desaturase. [source:refseq;acc:nm\_004265]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1442\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid desaturase 1; linoleoyl-coa desaturase (delta-6-desaturase)-like 1; delta-5 desaturase; delta-5 fatty acid desaturase. [source:refseq;acc:nm\_013402]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/